Join the discussion.

STAY UP TO DATE ON THE MOST IMPORTANT ISSUES IN GENETICS TODAY.

Back to full list

Recent Webinars

Diagnostic and therapeutic approaches to long QT syndrome (LQTS)

Michael J. Ackerman, M.D., Ph.D.
December 14, 2016
Series: Invitae Insights
View Recording

We are pleased to jointly present a three part medical education webinar series with the Sudden Arrhythmia Death Syndromes (SADS) Foundation. The series is designed to educate genetic counselors, physicians, and other healthcare providers about the care of families with inherited arrhythmias and implications for genetic testing.

In this second webinar, Michael J. Ackerman, M.D., Ph.D. presents the latest diagnostic and therapeutic approaches to long QT syndrome. 

Dr. Ackerman is the Windland Smith Rice Cardiovascular Genomics Research Professor and Professor of Medicine, Pediatrics, and Pharmacology at the Mayo Clinic in Rochester, Minnesota. He is a consultant in cardiovascular diseases and pediatric cardiology and serves as Director of Mayo Clinic’s Long QT Syndrome/Genetic Heart Rhythm Clinic and the Windland Smith Rice Sudden Death Genomics Laboratory.

Dr. Ackerman strives to fulfill the two-fold objective of medical education and biomedical research, as stated by Dr. Charles H. Mayo, “to heal the sick and to advance the science.”

 

Topic: Cardiology
Tags: LQTS

Latest Diagnostic and Treatment Strategies for ARVD/ARVC

Hugh Calkins, MD and Brittany Murray, CGC
November 22, 2016
Series: Invitae Insights
View Recording

We are pleased to jointly present a three part medical education webinar series with the Sudden Arrhythmia Death Syndromes (SADS) Foundation. The series is designed to educate genetic counselors, physicians, and other healthcare providers about the care of families with inherited arrhythmias and implications for genetic testing.

In this first webinar, Hugh Calkins, M.D. and Brittney Murray, M.S., CGC, both of The Johns Hopkins Hospital, discuss the latest diagnostic and treatment strategies for arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Dr. Calkins is the Nicholas J. Fortuin M.D. professor of cardiology and director of the electrophysiology laboratory and arrhythmia service at The Johns Hopkins Hospital.

Ms. Murray is the clinical genetic counselor/program coordinator of the Johns Hopkins Hospital ARVD/C program.

Topic: Cardiology
Tags: ARVD, ARVC

Diagnosis and management of hypertrophic cardiomyopathy

Dr. Christopher Semsarian, Director, Genetic Heart Disease and Hypertrophic Cardiomyopathy Clinic at Royal Prince Alfred Hospital, Sydney; Director, Australian Genetic Heart Disease Registry
May 18, 2015
Series: Invitae Insights
View Recording

Hypertrophic cardiomyopathy (HCM) is one of the most common single-gene inherited cardiovascular conditions and the most common cause of sudden cardiac death in athletes in the United States. It can present anytime from infancy through adulthood.

Defined by unexplained, abnormal thickening of the heart muscle, or myocardium, HCM can impair both how the heart contracts and the heart’s electrical system, leading to palpitations, dizziness, fainting, chest pain, shortness of breath, and, in some cases, sudden cardiac arrest or death.

Individuals with clinical symptoms of HCM may benefit from diagnostic genetic testing to better understand risks, confirm a diagnosis, and inform management. Asymptomatic individuals within a family with a known HCM mutation may also benefit, as testing may clarify their personal risk of developing HCM and allow for the consideration of medical management.

In this webinar, internationally renowned cardiologist and scientist Dr. Christopher Semsarian offers an overview of the diagnosis and management of HCM from a molecular, genetic, and clinical perspective, and discusses published HCM guidelines.

Topic: Cardiology